25
Jun 2026
Spermidine supplement improves COVID 19 vaccine response in older adults
As we age, the immune system gradually declines and becomes less effective at responding to infections and vaccines.
Stay Informed!
25
Jun 2026
Study identifies fPRDM16 as target for age-related pulmonary fibrosis
A study published recently in Current Molecular Pharmacology has uncovered a key mechanism linking aging to persistent pulmonary fibrosis, identifying the transcriptional regulator fPRDM16 as a potential therapeutic target.
25
Jun 2026
New review highlights TREM-1 receptor as target for inflammatory diseases
A comprehensive review recently published in Current Molecular Pharmacology consolidates the growing evidence surrounding the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) as a central amplifier of innate immune responses and a promising therapeutic target for a range of inflammatory diseases.
25
Jun 2026
Preoperative HMB supplement improves liver regeneration quality after major surgery
Taking a supplement before a hepatectomy, a surgery in which part of the liver is removed, may help the organ recover more quickly and become more resistant to further damage.
25
Jun 2026
AI-driven approach identifies promising new target for CAR T cell therapy
Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that firmly centers scientists' expertise to find viable target antigens for CAR T cell therapy.
25
Jun 2026
Chronic stress helps tumors evade immune attack through gut microbes
Chronic psychological stress can help tumors evade immune attack through a chain of molecular events involving gut bacteria and viruses within those bacteria, according to a study led by Weill Cornell Medicine investigators.
25
Jun 2026
Discovery of karyoptosis opens new therapeutic targets for Alzheimer's and frontotemporal dementia
Markers of a new mechanism for cell death, called karyoptosis, have been found in brains of patients with Alzheimer's disease and frontotemporal dementia (FTD).
25
Jun 2026
Targeting metabolic pathways could prevent relapse in KRAS-mutant cancers
Our cells rely on tightly regulated signaling pathways to control when they grow, divide, and survive. When these regulatory systems are disrupted, cells can acquire the ability to grow uncontrollably and become cancerous.
25
Jun 2026
Aston University receives funding to develop unique cancer-fighting 'magnetobots'
Aston University has been awarded €1.2m through the Marie Skłodowska-Curie Actions (MSCA) Staff Exchanges program for a project bringing together 18 partner organizations to develop unique cancer-fighting 'magnetobots'.
25
Jun 2026
Targeted investments can significantly reduce newborn deaths by 2040
A global analysis spanning 194 countries reveals a mixed picture for newborn survival: deaths caused by birth asphyxia, trauma, and prematurity have declined markedly since 2000, yet progress is slowing in many low- and middle-income countries, particularly across sub-Saharan Africa.
